These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A prospective randomized controlled clinical trial comparing the effects of somatostatin and vasopressin for control of acute variceal bleeding in the patients with liver cirrhosis. Lee HY; Lee HJ; Lee SM; Kim JH; Kweon SW; Lee BS; Kim NJ Korean J Intern Med; 2003 Sep; 18(3):161-6. PubMed ID: 14619385 [TBL] [Abstract][Full Text] [Related]
3. When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? Immediate control of bleeding by TIPS? Rössle M Langenbecks Arch Surg; 2003 Jul; 388(3):155-62. PubMed ID: 12728322 [TBL] [Abstract][Full Text] [Related]
4. Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide. Nevens F; Van Steenbergen W; Yap SH; Fevery J Gut; 1996 Jan; 38(1):129-34. PubMed ID: 8566840 [TBL] [Abstract][Full Text] [Related]
5. Octreotide in variceal bleeding. Burroughs AK Gut; 1994; 35(3 Suppl):S23-7. PubMed ID: 8206396 [TBL] [Abstract][Full Text] [Related]
6. Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis. Gøtzsche PC; Gjørup I; Bonnén H; Brahe NE; Becker U; Burcharth F BMJ; 1995 Jun; 310(6993):1495-8. PubMed ID: 7787594 [TBL] [Abstract][Full Text] [Related]
7. Pressure of intraoesophageal varices assessed by fine needle puncture: its relation to endoscopic signs and severity of liver disease in patients with cirrhosis. Kleber G; Sauerbruch T; Fischer G; Paumgartner G Gut; 1989 Feb; 30(2):228-32. PubMed ID: 2703144 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases. O'Donnell LJ; Farthing MJ Gut; 1989 Sep; 30(9):1165-72. PubMed ID: 2680792 [No Abstract] [Full Text] [Related]
9. The effects of sandostatin (Octreotide, SMS 201-995) infusion on splanchnic and hepatic blood flow in an experimental model of hepatic metastases. Hemingway DM; Jenkins SA; Cooke TG Br J Cancer; 1992 Mar; 65(3):396-8. PubMed ID: 1558793 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics. Kleber G; Sauerbruch T; Fischer G; Paumgartner G Gut; 1988 Feb; 29(2):153-6. PubMed ID: 2894336 [TBL] [Abstract][Full Text] [Related]
15. The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis. Nevens F; Sprengers D; Fevery J J Hepatol; 1994 Jan; 20(1):27-31. PubMed ID: 7911136 [TBL] [Abstract][Full Text] [Related]
16. The effect of somatostatin and octreotide on intravascular oesophageal variceal pressure in patients with cirrhosis. Avgerinos A; Armonis A; Rekoumis G; Manolakopoulos S; Argirakis G; Raptis S J Hepatol; 1995 Mar; 22(3):379-80. PubMed ID: 7608493 [No Abstract] [Full Text] [Related]